Last reviewed · How we verify

NCT04971148

Correlation of Peak Tidal Inspiratory Flow Measured Before and After Extubation in Adult Patients With Hypoxemia

Terminated NA Last updated 14 August 2023
What this trial tests

NA trial testing HFNC flow set at patient peak tidal inspiratory flow in Hypoxemic Respiratory Failure in 5 participants. Terminated before completion.

Timeline
7 April 2022
Primary endpoint
8 August 2023
8 August 2023

Quick facts

Lead sponsorRush University Medical Center
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment5
Start date7 April 2022
Primary completion8 August 2023
Estimated completion8 August 2023
Sites2 locations across United States, Spain

Drugs / interventions tested

Conditions studied

Sponsor

Rush University Medical Center

Who can join

Adults 18 to 90, any sex, with Hypoxemic Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, patients who are ready for extubation and indicated for high-flow nasal cannula therapy after extubation will be enrolled, the investigators would measure the patient peak tidal inspiratory flow (PTIF) pre and post extubation to explore the correlation between the two PTIFs. Moreover, different HFNC flows would be applied, to explore the patient response in terms of oxygenation and lung aeration to different flow ratios that matched and are above post-extubation PTIF.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypoxemic Respiratory Failure

Currently open trials in the same condition.

Other Rush University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04971148.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing